India’s doctors sound alarm over boom in availability of weight loss jabs

India's healthcare experts have raised concerns over the proliferation of weight loss injections like Mounjaro, Wegovy, and Ozempic in the country. While India is facing a growing epidemic of diabetes and obesity, doctors warn that the widespread and unregulated use of these weight loss drugs could put patients at risk. The demand for these appetite-suppressing drugs has surged since their introduction into the Indian market this year. However, healthcare professionals emphasize that these medications are not a magic solution to the country's health issues. They stress the need for a comprehensive approach that includes lifestyle changes, proper medical supervision, and addressing the underlying causes of obesity and diabetes. The article highlights the urgent need for regulation and oversight to ensure the safe and appropriate use of these weight loss drugs, as well as the importance of educating the public on the risks and limitations of such treatments. Doctors urge caution and emphasize the importance of seeking professional medical advice before embarking on any weight loss regimen.